TNFRSF10A and hepatocellular carcinoma: These results might help improve our understanding of how the biomarkers FGFR2, VEGF, TRAIL-R1, and TRAIL-R2 relate to recurrence, potentially yielding refinements to clinical staging systems and tumor recurrence predictions through improved stratification of HCC patients having undergone hepatic resection.